Perspective Therapeutics
$4.39
72
-$0.03-0.68% Today
Statistics
Day High
4.56
Day Low
4.22
52W High
6.16
52W Low
1.6
Volume
712,645
Avg. Volume
3,516,275
Mkt Cap
326.34M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19MayExpected
Expected EPS
-0.29166
Actual EPS
N/A
Financials
-5,452.48%Profit Margin
Unprofitable2.91MRevenue
-158.56MNet Income
Analyst Ratings
$12.63Average Price Target
The highest estimate is 16.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CATX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Pfizer
PFE
Mkt Cap140.15B
Merck
MRK
Mkt Cap214.76B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Roche
RHHBY
Mkt Cap258.9B
Astrazeneca
AZN
Mkt Cap256.58B
Gilead Sciences
GILD
Mkt Cap148.78B
AMGEN
AMGN
Mkt Cap160.66B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
About
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Show more...
CEO
Mr. Johan M. Spoor
Employees
138
Country
US
ISIN
US46489V3024
Listings
0 Comments
Share your thoughts
FAQ
What is Perspective Therapeutics stock price today?▼
The current price of CATX is $4.39 USD — it has decreased by -0.68% in the past 24 hours. Watch Perspective Therapeutics stock price performance more closely on the chart.
What is Perspective Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Perspective Therapeutics stocks are traded under the ticker CATX.
Is Perspective Therapeutics stock price growing?▼
CATX stock has risen by +4.03% compared to the previous week, the month change is a -17.94% fall, over the last year Perspective Therapeutics has showed a +114.15% increase.
What is Perspective Therapeutics market cap?▼
Today Perspective Therapeutics has the market capitalization of 326.34M
When is the next Perspective Therapeutics earnings date?▼
Perspective Therapeutics is going to release the next earnings report on May 19, 2026.
What were Perspective Therapeutics earnings last quarter?▼
CATX earnings for the last quarter are -0.51 USD per share, whereas the estimation was -0.36 USD resulting in a -40.61% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Perspective Therapeutics revenue for the last year?▼
Perspective Therapeutics revenue for the last year amounts to 2.91M USD.
What is Perspective Therapeutics net income for the last year?▼
CATX net income for the last year is -158.56M USD.
How many employees does Perspective Therapeutics have?▼
As of April 02, 2026, the company has 138 employees.
In which sector is Perspective Therapeutics located?▼
Perspective Therapeutics operates in the Health Care sector.
When did Perspective Therapeutics complete a stock split?▼
The last stock split for Perspective Therapeutics was on June 17, 2024 with a ratio of 1:10.
Where is Perspective Therapeutics headquartered?▼
Perspective Therapeutics is headquartered in Seattle, US.